Tetranov Pharmaceutical Co., Ltd.

Zhengzhou Taiji Hongnuo Pharmaceutical Technology Co., Ltd. was established in 2007 and is located in the South Campus of Zhengzhou University, a well-known domestic university. It is a biomedical high-tech Sino-foreign joint venture focusing on the research and development of new drugs. The founders are a group of senior researchers in the field of biomedical technology who have returned from overseas. Among them are senior professionals who have been engaged in R&D and management in well-known biomedical companies around the world for many years. The company currently has a strong R&D team and strong scientific research strength, including 5 Ph.D.s, 5 Ph.D. candidates, and more than 20 master's students. The company's chairman, Dr. Wu Yusheng, was selected into the "Thousand Talents Plan" of the Organization Department of the Central Committee of the CPC in 2011 and was selected into the Henan Province in the same year. Provincial "Hundred Talents Plan". The company has a new drug development department and a chemistry department. The New Drug Development Department consists of new drug synthesis, drug analysis, drug preparation, new drug approval and other departments. It currently carries out more than 10 international cutting-edge new drug research and development projects, including anti-lung cancer, hypolipidemia, Alzheimer's disease, leukemia, hepatitis C, breast cancer, etc. More than 10 patent applications have been submitted for drug research and development, and many projects have obtained national invention patents. Among them, anti-lung cancer drugs have obtained technology transfer and technology sharing with other companies, and have launched in-depth cooperation. The Chemistry Department mainly undertakes the customization of international and domestic chemical and pharmaceutical intermediates, provides customers with pharmaceutical chemical process optimization and other related technical services, and undertakes compound molecular libraries. It has a strong production team and strong scientific research and production capabilities. Orders mainly come from well-known European and American pharmaceutical companies. As well as major domestic large-scale pharmaceutical R&D enterprises, Tetranov international. inc, an American company, is located in New Jersey. The laboratory covers an area of ​​more than 5,000 square meters and has complete experimental and analytical conditions. It is equipped with 400-megatron nuclear magnetic resonance, liquid mass spectrometry, GC-MS chromatography, high-resolution mass spectrometry, infrared spectroscopy, high-performance liquid chromatography, gas chromatography, and hydrogen generators. , elemental analysis instruments, 5-liter high-pressure reactor, 20-liter reactor, etc. The company has an excellent academic environment and rich cultural atmosphere. It has established a strategic cooperative relationship with Zhengzhou University that combines industry, academia and research to jointly cultivate high-level talents in pharmaceutical science and technology. It has trained more than 30 master's students so far. Taijihongnuo continues to pursue scientific and technological innovation, actively promotes the development of the global pharmaceutical industry, and contributes to the life and health of human society. The company's goal is to build Taijihongnuo into an international innovative pharmaceutical company with leading technology.